Arrowhead Pharmaceuticals Market Cap

Arrowhead Pharmaceuticals has a market cap or net worth of $12.49 billion as of July 23, 2026. Its market cap has increased by 515.01% in one year.

Market Cap

12.49B

Enterprise Value

12.10B

1-Year Change

515.01%

Ranking

#825

ChartMarket Cap Chart

Chart

Since January 15, 2004, Arrowhead Pharmaceuticals's market cap has increased from $300.00K to $12.49B, an increase of 4,164,572.59%. That is a compound annual growth rate of 60.33%.

Market Cap History

Date	Market Cap	% Change
Jul 22, 2026	12.49B	38.57%
Dec 31, 2025	9.02B	285.42%
Dec 31, 2024	2.34B	-28.84%
Dec 29, 2023	3.29B	-23.54%
Dec 30, 2022	4.30B	-37.84%
Dec 31, 2021	6.92B	-11.95%
Dec 31, 2020	7.86B	29.67%
Dec 31, 2019	6.06B	451.13%
Dec 31, 2018	1.10B	299.42%
Dec 29, 2017	275.20M	154.58%
Dec 30, 2016	108.10M	-70.48%
Dec 31, 2015	366.20M	-9.27%
Dec 31, 2014	403.60M	-3.88%
Dec 31, 2013	419.90M	1,153.43%
Dec 31, 2012	33.50M	-24.04%
Dec 30, 2011	44.10M	-31.42%
Dec 31, 2010	64.30M	93.09%
Dec 31, 2009	33.30M	-15.70%
Dec 31, 2008	39.50M	-72.93%
Dec 31, 2007	145.90M	-2.60%
Dec 29, 2006	149.80M	25.99%
Dec 30, 2005	118.90M	101.87%
Dec 31, 2004	58.90M	19,533.33%
Jan 15, 2004	300.00K	-

View and export this data all the way back to 2004. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Jazz Pharmaceuticals	15.76B
Exelixis	13.86B
Madrigal Pharmaceuticals	12.39B
Axsome Therapeutics	12.29B
ABIVAX Société Anonyme	11.56B
Summit Therapeutics	11.49B
Cytokinetics	11.34B
BioMarin Pharmaceutical	11.32B

Market Cap Rankings